Allergan
Allergan plc (NYSE: AGN), headquartered in Dublin, Ireland, is a bold, global pharmaceutical leader. Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world.
Allergan plc
Clonshaugh Business and Technology Park
Coolock, Dublin, D17 E400 Ireland
U.S. Administrative Headquarters
5 Giralda Farms
Madison, NJ 07940
+1 (862) 261-7000
RELATED ARTICLES
How Innovation Ended My Daily Battle with Headache and Migraine
After 25 trials, a new migraine treatment gave Jennifer her life back after years of pain.
READ MORE
Researcher Profile: Dr. Joel Trugman
Joel and biopharmaceutical researchers like him work to develop new therapies that prevent migraines…
READ MORE
Finding Migraine Relief
More than 38 million Americans suffer from migraines, but thanks to new advanced treatments, that nu…
READ MOREPOPULAR ARTICLES
Can We Afford the New Era of Medicine?
Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.
READ MORE
Researcher Profile: Jirong Lu
Dr. Jirong Lu, a distinguished research fellow at Eli Lilly and Company (Lilly), traces the beginnings of her career to a high school fascination with chemistry.
READ MORE
We Cannot Take Progress for Granted
We are in a new era of medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we must not take this progress for granted.
READ MORE
The Greatest Gift of All: Hope
My son Parker's journey with juvenile arthritis (JA) began 10 years ago when he was in elementary school.
READ MORE
Migraine: More than Just a Bad Headache
Migraine is a debilitating neurological disease that is often misunderstood by those who do not suffer symptoms, according to the Migraine Impact Report, a new survey recently released by Eli Lilly and Company and conducted by Nielsen.
READ MORE
Washington is considering policy changes that could threaten innovation
New policy proposals in Washington threaten to hamstring investment in innovation and jeopardize breakthroughs.
READ MORE
Tackling Neurological Disorders in New Ways
Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.
READ MORE